Regent Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $5.61M | Sell |
109,392
-1,475
| -1% | -$70.7K | 1.5% | 14 |
|
|
2022
Q3 | $4.85M | Sell |
110,867
-375
| -0.3% | -$18.2K | 1.42% | 16 |
|
|
2022
Q2 | $5.83M | Sell |
111,242
-1,188
| -1% | -$60.5K | 1.63% | 14 |
|
|
2022
Q1 | $5.82M | Hold |
112,430
| – | – | 1.35% | 15 |
|
|
2021
Q4 | $6.64M | Sell |
112,430
-240
| -0.2% | -$11.9K | 1.45% | 15 |
|
|
2021
Q3 | $4.85M | Sell |
112,670
-1,372
| -1% | -$60.8K | 1.16% | 18 |
|
|
2021
Q2 | $4.47M | Buy |
114,042
+2,101
| +2% | +$81.7K | 1.05% | 23 |
|
|
2021
Q1 | $4.06M | Buy |
111,941
+1,460
| +1% | +$51.8K | 1.02% | 23 |
|
|
2020
Q4 | $4.07M | Buy |
110,481
+36,779
| +50% | +$1.35M | 1.13% | 20 |
|
|
2020
Q3 | $2.57M | Sell |
73,702
-3,623
| -5% | -$127K | 0.79% | 32 |
|
|
2020
Q2 | $2.4M | Buy |
77,325
+20,632
| +36% | +$701K | 0.8% | 32 |
|
|
2020
Q1 | $1.75M | Sell |
56,693
-579
| -1% | -$19.7K | 0.72% | 38 |
|
|
2019
Q4 | $2.13M | Sell |
57,272
-2,288
| -4% | -$81.5K | 0.65% | 46 |
|
|
2019
Q3 | $2.03M | Buy |
59,560
+316
| +0.5% | +$11.5K | 0.67% | 49 |
|
|
2019
Q2 | $2.44M | Sell |
59,244
-1,002
| -2% | -$39.8K | 0.79% | 38 |
|
|
2019
Q1 | $2.43M | Buy |
60,246
+1,146
| +2% | +$45.9K | 0.81% | 37 |
|
|
2018
Q4 | $2.45M | Sell |
59,100
-3,651
| -6% | -$152K | 0.92% | 29 |
|
|
2018
Q3 | $2.62M | Sell |
62,751
-3,130
| -5% | -$120K | 0.82% | 35 |
|
|
2018
Q2 | $2.27M | Sell |
65,881
-1,688
| -2% | -$57.7K | 0.76% | 40 |
|
|
2018
Q1 | $2.27M | Sell |
67,569
-764
| -1% | -$26.3K | 0.77% | 39 |
|
|
2017
Q4 | $2.35M | Sell |
68,333
-87
| -0.1% | -$2.97K | 0.77% | 38 |
|
|
2017
Q3 | $2.32M | Sell |
68,420
-923
| -1% | -$29.7K | 0.78% | 34 |
|
|
2017
Q2 | $2.21M | Buy |
69,343
+109
| +0.2% | +$3.44K | 0.78% | 37 |
|
|
2017
Q1 | $2.25M | Buy |
69,234
+18,102
| +35% | +$571K | 0.85% | 34 |
|
|
2016
Q4 | $1.58M | Buy |
51,132
+2,372
| +5% | +$72.4K | 0.81% | 33 |
|
|
2016
Q3 | $1.57M | Buy |
48,760
+3,973
| +9% | +$133K | 0.81% | 32 |
|
|
2016
Q2 | $1.5M | Buy |
44,787
+9,196
| +26% | +$293K | 0.81% | 36 |
|
|
2016
Q1 | $1M | Buy |
35,591
+15,579
| +78% | +$445K | 0.56% | 52 |
|
|
2015
Q4 | $613K | Sell |
20,012
-185
| -0.9% | -$5.82K | 0.33% | 89 |
|
|
2015
Q3 | $602K | Buy |
20,197
+14,260
| +240% | +$457K | 0.33% | 88 |
|
|
2015
Q2 | $189K | Hold |
5,937
| – | – | 0.1% | 173 |
|
|
2015
Q1 | $196K | Sell |
5,937
-2,287
| -28% | -$72.7K | 0.1% | 176 |
|
|
2014
Q4 | $243K | Hold |
8,224
| – | – | 0.12% | 171 |
|
|
2014
Q3 | $231K | Hold |
8,224
| – | – | 0.12% | 169 |
|
|
2014
Q2 | $232K | Hold |
8,224
| – | – | 0.11% | 167 |
|
|
2014
Q1 | $251K | Hold |
8,224
| – | – | 0.13% | 159 |
|
|
2013
Q4 | $239K | Buy |
+8,224
| New | +$239K | 0.13% | 157 |
|
Other funds holding PFE
AWA
Regent Investment Management's PFE Position: Q4 2022 in Review
Regent Investment Management reduced its Pfizer (PFE) stake by 1.3% in Q4 2022, selling an estimated $70.7K and leaving 109,392 shares worth $5.61M. The position accounts for 1.5% of the portfolio, ranked #14.
Regent Investment Management first reported a position in PFE in Q4 2013 and has held it in 37 quarters since. The position peaked at $6.64M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Regent Investment Management held 109,392 shares of Pfizer worth $5.61M as of Q4 2022.
- Regent Investment Management sold 1,475 Pfizer shares in Q4 2022, an estimated $70.7K.
- Pfizer made up 1.5% of Regent Investment Management's portfolio in Q4 2022, its #14 holding.
- Regent Investment Management first reported a position in Pfizer in Q4 2013 and has held it in 37 quarters since.
- Regent Investment Management's Pfizer position peaked at $6.64M in Q4 2021.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.